Delphia (USA)’s Compugen CGEN Stock Holding History

Delphia (USA)’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,791	Closed	-$64K	–	338
2021 Q4	$64K	Buy	+14,791	New	+$80K	0.07%	261

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Delphia (USA)'s CGEN Position: Q1 2022 in Review

Delphia (USA) sold out of Compugen (CGEN) in Q1 2022, closing a stake of 14,791 shares — an estimated $64K sold.

Delphia (USA) first reported a position in CGEN in Q4 2021 and held it in 1 quarter. The position peaked at $64K in Q4 2021. 110 funds tracked by Wall St. Rank hold CGEN as of Q1 2022.

Delphia (USA) reported no remaining Compugen position as of Q1 2022 after selling out during the quarter.
Delphia (USA) sold 14,791 Compugen shares in Q1 2022, an estimated $64K.
Delphia (USA) first reported a position in Compugen in Q4 2021 and held it in 1 quarter.
Delphia (USA)'s Compugen position peaked at $64K in Q4 2021.
110 funds tracked by Wall St. Rank held Compugen as of Q1 2022.

Based on Delphia (USA)'s 13F filing for Q1 2022, filed 16 May 2022.